Reflectance Confocal Imaging in Cervical Cancer Patients

Sponsor
M.D. Anderson Cancer Center (Other)
Overall Status
Completed
CT.gov ID
NCT00505726
Collaborator
National Cancer Institute (NCI) (NIH)
39
4
70
9.8
0.1

Study Details

Study Description

Brief Summary

The goal of this clinical research study is to see if reflectance confocal microscopy works as well as standard methods to detect cancer of the cervix or precancerous lesions.

Primary Objectives:
  1. To identify potential clinical advantages for a noninvasive method of diagnosing dysplasia and neoplasia in the cervix using reflectance confocal microscopy.

  2. To obtain real time reflected light images in vivo of sites in the human cervix.

  3. To access the effects of acetic acid as a contrast agent for in vivo reflectance confocal imaging.

  4. Evaluate the depth of penetration for the fiber optic confocal device and analyze the diagnostic value of images taken from different depths.

  5. Determine the sensitivity and specificity of this device for the diagnosis of CIN.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Reflectance Confocal Imaging

Detailed Description

Confocal microscopy may be a new way to detect lesions of the cervix quickly without removing a tissue sample. Women in the study will already be scheduled for colposcopy to detect or treat cervical lesions. (A colposcopy is an exam of the vagina and cervix using a magnifying lens.)

Microscopic images will be taken during the routine colposcopy in the outpatient clinic. A disinfected probe will be inserted into the vagina and placed against the cervix. . The probe sends out laser light and detects reflected light from the tissue. Images of cervical tissue will be formed and displayed on a computer monitor. 1-3 regions of the cervix will be imaged (2 abnormal and one normal), and each will take about 1-2 minutes.

Each imaged site will be biopsied. The biopsies will be analyzed by the research pathologist. The results will be available to participants in the event that care needs to be given. Total participation in this study will be only a few minutes.

This is an investigational study. About 72 women will take part in this study. About 18 will be enrolled at M. D. Anderson.

Study Design

Study Type:
Observational
Actual Enrollment :
39 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Reflectance Confocal Imaging of Cervical Intraepithelial Neoplasia (CIN)
Study Start Date :
Nov 1, 2001
Actual Primary Completion Date :
Sep 1, 2007
Actual Study Completion Date :
Sep 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Confocal Microscopy

Procedure: Reflectance Confocal Imaging
Microscopic images taken during routine colposcopy where disinfected probe inserted into vagina and placed against cervix, 1-3 regions imaged (2 abnormal and one normal), and each taking about 1-2 minutes.

Outcome Measures

Primary Outcome Measures

  1. Reflectance confocal images of cervical tissue in vivo [1-2 minutes during routine colposcopy]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subjects will be individuals 18 years of age or older, who have voluntarily responded to advertisement in the form of posted flyers or word of mouth.

  • Subjects must sign an informed consent indicating awareness of the investigational nature of this study.

Exclusion Criteria:
  • Pregnant individuals will be ineligible for this study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lyndon B. Johnson Hospital Houston Texas United States 77030
2 U. T. Health Science Center Houston Texas United States 77030
3 U.T.M.D. Anderson Cancer Center Houston Texas United States 77030
4 British Columbia Cancer Research Center Vancouver British Columbia Canada

Sponsors and Collaborators

  • M.D. Anderson Cancer Center
  • National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Michele Follen, MD, PhD, M.D. Anderson Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00505726
Other Study ID Numbers:
  • ID01-555
  • CA82880
First Posted:
Jul 23, 2007
Last Update Posted:
Aug 1, 2012
Last Verified:
Jul 1, 2012

Study Results

No Results Posted as of Aug 1, 2012